PMID: 16685245

Raloxifene (Evista) for breast cancer prevention in postmenopausal women.

The Medical letter on drugs and therapeutics · 2006

Vol. 48, Issue 1234, pp. 37

This entry links to third-party literature. For research use only.

Breast NeoplasmsFemaleHumansIncidenceNeoplasm InvasivenessPostmenopauseRaloxifene HydrochlorideRandomized Controlled Trials as TopicSelective Estrogen Receptor ModulatorsTamoxifen

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.